title: FK 506 induction and rescue therapy in pancreas transplant recipients.
authors.affiliation: University of Nebraska Medical Center, Omaha 68198-3280, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Stratta
authors.forename: R J
authors.initials: RJ
authors.lastname: Taylor
authors.forename: P
authors.initials: P
authors.lastname: Castaldo
authors.forename: R
authors.initials: R
authors.lastname: Sindhi
authors.forename: D
authors.initials: D
authors.lastname: Sudan
authors.forename: L G
authors.initials: LG
authors.lastname: Weide
authors.forename: K
authors.initials: K
authors.lastname: Frisbie
authors.forename: K A
authors.initials: KA
authors.lastname: Cushing
authors.forename: J
authors.initials: J
authors.lastname: Jerius
authors.forename: S J
authors.initials: SJ
authors.lastname: Radio
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus